The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Sepsis Diagnostics Market Research Report 2025

Global Sepsis Diagnostics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1805879

No of Pages : 92

Ask Your Query

Synopsis

Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.

Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.

The global Sepsis Diagnostics market was valued at US$ 360.5 million in 2023 and is anticipated to reach US$ 528.8 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
North America is expected to command the largest share of the market in 2018, due to the growing prevalence of sepsis, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.

This report aims to provide a comprehensive presentation of the global market for Sepsis Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Diagnostics.

Report Scope

The Sepsis Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sepsis Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company(Partial List)

  • Biomerieux
  • T2 Biosystems
  • Luminex
  • Becton, Dickinson
  • Roche
  • Danaher
  • Thermo Fisher
  • Bruker
  • Abbott
  • Immunexpress
  • Response Biomedical
  • Axis-Shield Diagnostics
  • Cytosorbents
  • Mitsubishi Chemical
  • EKF Diagnostics

Segment by Type

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

Segment by Application

  • Hospitals
  • Pathology & Reference Laboratories

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sepsis Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Microbiology
1.2.3 Molecular Diagnostics
1.2.4 Immunoassays
1.2.5 Flow Cytometry
1.2.6 Microfluidics
1.2.7 Biomarkers
1.3 Market by Application
1.3.1 Global Sepsis Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Pathology & Reference Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Diagnostics Market Perspective (2019-2030)
2.2 Sepsis Diagnostics Growth Trends by Region
2.2.1 Global Sepsis Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sepsis Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Sepsis Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Sepsis Diagnostics Market Dynamics
2.3.1 Sepsis Diagnostics Industry Trends
2.3.2 Sepsis Diagnostics Market Drivers
2.3.3 Sepsis Diagnostics Market Challenges
2.3.4 Sepsis Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostics Players by Revenue
3.1.1 Global Top Sepsis Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Sepsis Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Sepsis Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sepsis Diagnostics Revenue
3.4 Global Sepsis Diagnostics Market Concentration Ratio
3.4.1 Global Sepsis Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostics Revenue in 2023
3.5 Sepsis Diagnostics Key Players Head office and Area Served
3.6 Key Players Sepsis Diagnostics Product Solution and Service
3.7 Date of Enter into Sepsis Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Diagnostics Breakdown Data by Type
4.1 Global Sepsis Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Sepsis Diagnostics Forecasted Market Size by Type (2025-2030)
5 Sepsis Diagnostics Breakdown Data by Application
5.1 Global Sepsis Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Sepsis Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sepsis Diagnostics Market Size (2019-2030)
6.2 North America Sepsis Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sepsis Diagnostics Market Size by Country (2019-2024)
6.4 North America Sepsis Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sepsis Diagnostics Market Size (2019-2030)
7.2 Europe Sepsis Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sepsis Diagnostics Market Size by Country (2019-2024)
7.4 Europe Sepsis Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Sepsis Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sepsis Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Sepsis Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sepsis Diagnostics Market Size (2019-2030)
9.2 Latin America Sepsis Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sepsis Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Sepsis Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Sepsis Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sepsis Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Sepsis Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biomerieux
11.1.1 Biomerieux Company Detail
11.1.2 Biomerieux Business Overview
11.1.3 Biomerieux Sepsis Diagnostics Introduction
11.1.4 Biomerieux Revenue in Sepsis Diagnostics Business (2019-2024)
11.1.5 Biomerieux Recent Development
11.2 T2 Biosystems
11.2.1 T2 Biosystems Company Detail
11.2.2 T2 Biosystems Business Overview
11.2.3 T2 Biosystems Sepsis Diagnostics Introduction
11.2.4 T2 Biosystems Revenue in Sepsis Diagnostics Business (2019-2024)
11.2.5 T2 Biosystems Recent Development
11.3 Luminex
11.3.1 Luminex Company Detail
11.3.2 Luminex Business Overview
11.3.3 Luminex Sepsis Diagnostics Introduction
11.3.4 Luminex Revenue in Sepsis Diagnostics Business (2019-2024)
11.3.5 Luminex Recent Development
11.4 Becton, Dickinson
11.4.1 Becton, Dickinson Company Detail
11.4.2 Becton, Dickinson Business Overview
11.4.3 Becton, Dickinson Sepsis Diagnostics Introduction
11.4.4 Becton, Dickinson Revenue in Sepsis Diagnostics Business (2019-2024)
11.4.5 Becton, Dickinson Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Sepsis Diagnostics Introduction
11.5.4 Roche Revenue in Sepsis Diagnostics Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Danaher
11.6.1 Danaher Company Detail
11.6.2 Danaher Business Overview
11.6.3 Danaher Sepsis Diagnostics Introduction
11.6.4 Danaher Revenue in Sepsis Diagnostics Business (2019-2024)
11.6.5 Danaher Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Detail
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Sepsis Diagnostics Introduction
11.7.4 Thermo Fisher Revenue in Sepsis Diagnostics Business (2019-2024)
11.7.5 Thermo Fisher Recent Development
11.8 Bruker
11.8.1 Bruker Company Detail
11.8.2 Bruker Business Overview
11.8.3 Bruker Sepsis Diagnostics Introduction
11.8.4 Bruker Revenue in Sepsis Diagnostics Business (2019-2024)
11.8.5 Bruker Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Sepsis Diagnostics Introduction
11.9.4 Abbott Revenue in Sepsis Diagnostics Business (2019-2024)
11.9.5 Abbott Recent Development
11.10 Immunexpress
11.10.1 Immunexpress Company Detail
11.10.2 Immunexpress Business Overview
11.10.3 Immunexpress Sepsis Diagnostics Introduction
11.10.4 Immunexpress Revenue in Sepsis Diagnostics Business (2019-2024)
11.10.5 Immunexpress Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Detail
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Sepsis Diagnostics Introduction
11.11.4 Response Biomedical Revenue in Sepsis Diagnostics Business (2019-2024)
11.11.5 Response Biomedical Recent Development
11.12 Axis-Shield Diagnostics
11.12.1 Axis-Shield Diagnostics Company Detail
11.12.2 Axis-Shield Diagnostics Business Overview
11.12.3 Axis-Shield Diagnostics Sepsis Diagnostics Introduction
11.12.4 Axis-Shield Diagnostics Revenue in Sepsis Diagnostics Business (2019-2024)
11.12.5 Axis-Shield Diagnostics Recent Development
11.13 Cytosorbents
11.13.1 Cytosorbents Company Detail
11.13.2 Cytosorbents Business Overview
11.13.3 Cytosorbents Sepsis Diagnostics Introduction
11.13.4 Cytosorbents Revenue in Sepsis Diagnostics Business (2019-2024)
11.13.5 Cytosorbents Recent Development
11.14 Mitsubishi Chemical
11.14.1 Mitsubishi Chemical Company Detail
11.14.2 Mitsubishi Chemical Business Overview
11.14.3 Mitsubishi Chemical Sepsis Diagnostics Introduction
11.14.4 Mitsubishi Chemical Revenue in Sepsis Diagnostics Business (2019-2024)
11.14.5 Mitsubishi Chemical Recent Development
11.15 EKF Diagnostics
11.15.1 EKF Diagnostics Company Detail
11.15.2 EKF Diagnostics Business Overview
11.15.3 EKF Diagnostics Sepsis Diagnostics Introduction
11.15.4 EKF Diagnostics Revenue in Sepsis Diagnostics Business (2019-2024)
11.15.5 EKF Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Sepsis Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Microbiology
Table 3. Key Players of Molecular Diagnostics
Table 4. Key Players of Immunoassays
Table 5. Key Players of Flow Cytometry
Table 6. Key Players of Microfluidics
Table 7. Key Players of Biomarkers
Table 8. Global Sepsis Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Sepsis Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Sepsis Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Sepsis Diagnostics Market Share by Region (2019-2024)
Table 12. Global Sepsis Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Sepsis Diagnostics Market Share by Region (2025-2030)
Table 14. Sepsis Diagnostics Market Trends
Table 15. Sepsis Diagnostics Market Drivers
Table 16. Sepsis Diagnostics Market Challenges
Table 17. Sepsis Diagnostics Market Restraints
Table 18. Global Sepsis Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Sepsis Diagnostics Market Share by Players (2019-2024)
Table 20. Global Top Sepsis Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostics as of 2023)
Table 21. Ranking of Global Top Sepsis Diagnostics Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Sepsis Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Sepsis Diagnostics Product Solution and Service
Table 25. Date of Enter into Sepsis Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Sepsis Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Sepsis Diagnostics Revenue Market Share by Type (2019-2024)
Table 29. Global Sepsis Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Sepsis Diagnostics Revenue Market Share by Type (2025-2030)
Table 31. Global Sepsis Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Sepsis Diagnostics Revenue Market Share by Application (2019-2024)
Table 33. Global Sepsis Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Sepsis Diagnostics Revenue Market Share by Application (2025-2030)
Table 35. North America Sepsis Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Sepsis Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Sepsis Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Sepsis Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Sepsis Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Sepsis Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Sepsis Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Sepsis Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Sepsis Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Sepsis Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Sepsis Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Sepsis Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Sepsis Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Sepsis Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Sepsis Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 50. Biomerieux Company Detail
Table 51. Biomerieux Business Overview
Table 52. Biomerieux Sepsis Diagnostics Product
Table 53. Biomerieux Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 54. Biomerieux Recent Development
Table 55. T2 Biosystems Company Detail
Table 56. T2 Biosystems Business Overview
Table 57. T2 Biosystems Sepsis Diagnostics Product
Table 58. T2 Biosystems Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 59. T2 Biosystems Recent Development
Table 60. Luminex Company Detail
Table 61. Luminex Business Overview
Table 62. Luminex Sepsis Diagnostics Product
Table 63. Luminex Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 64. Luminex Recent Development
Table 65. Becton, Dickinson Company Detail
Table 66. Becton, Dickinson Business Overview
Table 67. Becton, Dickinson Sepsis Diagnostics Product
Table 68. Becton, Dickinson Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 69. Becton, Dickinson Recent Development
Table 70. Roche Company Detail
Table 71. Roche Business Overview
Table 72. Roche Sepsis Diagnostics Product
Table 73. Roche Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 74. Roche Recent Development
Table 75. Danaher Company Detail
Table 76. Danaher Business Overview
Table 77. Danaher Sepsis Diagnostics Product
Table 78. Danaher Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 79. Danaher Recent Development
Table 80. Thermo Fisher Company Detail
Table 81. Thermo Fisher Business Overview
Table 82. Thermo Fisher Sepsis Diagnostics Product
Table 83. Thermo Fisher Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 84. Thermo Fisher Recent Development
Table 85. Bruker Company Detail
Table 86. Bruker Business Overview
Table 87. Bruker Sepsis Diagnostics Product
Table 88. Bruker Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 89. Bruker Recent Development
Table 90. Abbott Company Detail
Table 91. Abbott Business Overview
Table 92. Abbott Sepsis Diagnostics Product
Table 93. Abbott Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 94. Abbott Recent Development
Table 95. Immunexpress Company Detail
Table 96. Immunexpress Business Overview
Table 97. Immunexpress Sepsis Diagnostics Product
Table 98. Immunexpress Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 99. Immunexpress Recent Development
Table 100. Response Biomedical Company Detail
Table 101. Response Biomedical Business Overview
Table 102. Response Biomedical Sepsis Diagnostics Product
Table 103. Response Biomedical Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 104. Response Biomedical Recent Development
Table 105. Axis-Shield Diagnostics Company Detail
Table 106. Axis-Shield Diagnostics Business Overview
Table 107. Axis-Shield Diagnostics Sepsis Diagnostics Product
Table 108. Axis-Shield Diagnostics Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 109. Axis-Shield Diagnostics Recent Development
Table 110. Cytosorbents Company Detail
Table 111. Cytosorbents Business Overview
Table 112. Cytosorbents Sepsis Diagnostics Product
Table 113. Cytosorbents Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 114. Cytosorbents Recent Development
Table 115. Mitsubishi Chemical Company Detail
Table 116. Mitsubishi Chemical Business Overview
Table 117. Mitsubishi Chemical Sepsis Diagnostics Product
Table 118. Mitsubishi Chemical Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 119. Mitsubishi Chemical Recent Development
Table 120. EKF Diagnostics Company Detail
Table 121. EKF Diagnostics Business Overview
Table 122. EKF Diagnostics Sepsis Diagnostics Product
Table 123. EKF Diagnostics Revenue in Sepsis Diagnostics Business (2019-2024) & (US$ Million)
Table 124. EKF Diagnostics Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sepsis Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Sepsis Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Microbiology Features
Figure 4. Molecular Diagnostics Features
Figure 5. Immunoassays Features
Figure 6. Flow Cytometry Features
Figure 7. Microfluidics Features
Figure 8. Biomarkers Features
Figure 9. Global Sepsis Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Sepsis Diagnostics Market Share by Application: 2023 VS 2030
Figure 11. Hospitals Case Studies
Figure 12. Pathology & Reference Laboratories Case Studies
Figure 13. Sepsis Diagnostics Report Years Considered
Figure 14. Global Sepsis Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Sepsis Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Sepsis Diagnostics Market Share by Region: 2023 VS 2030
Figure 17. Global Sepsis Diagnostics Market Share by Players in 2023
Figure 18. Global Top Sepsis Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostics as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Sepsis Diagnostics Revenue in 2023
Figure 20. North America Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Sepsis Diagnostics Market Share by Country (2019-2030)
Figure 22. United States Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Sepsis Diagnostics Market Share by Country (2019-2030)
Figure 26. Germany Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Sepsis Diagnostics Market Share by Region (2019-2030)
Figure 34. China Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Sepsis Diagnostics Market Share by Country (2019-2030)
Figure 42. Mexico Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Sepsis Diagnostics Market Share by Country (2019-2030)
Figure 46. Turkey Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Sepsis Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Biomerieux Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 49. T2 Biosystems Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 50. Luminex Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 51. Becton, Dickinson Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 52. Roche Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 53. Danaher Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 54. Thermo Fisher Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 55. Bruker Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 56. Abbott Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 57. Immunexpress Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 58. Response Biomedical Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 59. Axis-Shield Diagnostics Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 60. Cytosorbents Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 61. Mitsubishi Chemical Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 62. EKF Diagnostics Revenue Growth Rate in Sepsis Diagnostics Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock